penicillamine has been researched along with Leishmaniasis, Cutaneous in 2 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Jaramillo, P | 1 |
| Ruano, C | 1 |
| Rivera, J | 1 |
| Terán, E | 1 |
| Salazar-Irigoyen, R | 1 |
| Esplugues, JV | 1 |
| Moncada, S | 1 |
| Niedbala, W | 1 |
| Wei, XQ | 1 |
| Piedrafita, D | 1 |
| Xu, D | 1 |
| Liew, FY | 1 |
1 trial available for penicillamine and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Treatment of cutaneous leishmaniasis with nitric-oxide donor.
Topics: Administration, Topical; Adolescent; Adult; Animals; Child; Child, Preschool; Dose-Response Relation | 1998 |
1 other study available for penicillamine and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Effects of nitric oxide on the induction and differentiation of Th1 cells.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Clone Cells; Drug Synergism; Enzyme Inhib | 1999 |